Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Consolidated Net Income (2025 - 2026)

Updated

Kardigan (KARD) recorded Consolidated Net Income of -$60.44 million in Q3 2026, compared with -$60.21 million a year earlier.

Analysis

Kardigan (KARD) Consolidated Net Income (2025 - 2026) Analysis & Trends

On a TTM basis, Kardigan's Consolidated Net Income came in at -$289.25 million as of Sep 30, 2026; for FY2025, it was -$191.88 million.

  • Across earlier years, Consolidated Net Income came in at -$88.66 million in FY2024.
  • Quarterly Consolidated Net Income has ranged from -$116.38 million in Q2 2026 to -$18.02 million in Q1 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$116.38 million (Q2 2026), -$56.22 million (Q1 2026) and -$56.21 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 210.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.22 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.25 Bn
10 Kardigan 1.29 Bn -398.44 Mn - -60.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -60.44 Mn
Jun 30, 2026 -116.38 Mn
Mar 31, 2026 -56.22 Mn
Jun 30, 2025 -57.45 Mn
Mar 31, 2025 -18.02 Mn
API Access

Kardigan Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KARD&period=max&api_key=YOUR_API_KEY